Sandhya Sapra

A Controlled Trial of Erenumab for Episodic Migraine

Peter J. Goadsby, Uwe Reuter, Yngve Hallström et al. · New England Journal of Medicine · 2017 · 948 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States

Machaon Bonafede, Sandhya Sapra, Neel Shah et al. · Headache The Journal of Head and Face Pain · 2018 · 252 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches

Sally Mannix, Anne Skalicky, Dawn C. Buse et al. · Health and Quality of Life Outcomes · 2016 · 94 citations · Full text

Medicine, Neurology, Pain Management +13

Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab

Dawn C. Buse, Richard B. Lipton, Yngve Hallström et al. · Cephalalgia · 2018 · 91 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective

Richard B. Lipton, Alan Brennan, Stephen Palmer et al. · Journal of Medical Economics · 2018 · 63 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17